Xueying Liu
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
A trimeric spike-based COVID-19 vaccine candidate induces broad neutralization against SARS-CoV-2 variants.
Journal: Human vaccines & immunotherapeutics
Published: March 08, 2023
Protein transduction domain-mediated influenza NP subunit vaccine generates a potent immune response and protection against influenza virus in mice.
Journal: Emerging microbes & infections
Published: August 20, 2020
Safety and immunogenicity of an alum-adjuvanted whole-virion H7N9 influenza vaccine: a randomized, blinded, clinical trial.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: February 03, 2020
MiRNA Targeted NP Genome of Live Attenuated Influenza Vaccines Provide Cross-Protection against a Lethal Influenza Virus Infection.
Journal: Vaccines
Published: November 28, 2019
Correction: Transcriptomic analysis reveals the roles of gibberellin-regulated genes and transcription factors in regulating bolting in lettuce (Lactuca sativa L.).
Journal: PloS one
Published: August 29, 2019
Immunization with DNA prime-subunit protein boost strategy based on influenza H9N2 virus conserved matrix protein M1 and its epitope screening.
Journal: Scientific reports
Published: October 08, 2018
Intranasal Administration of Chitosan Against Influenza A (H7N9) Virus Infection in a Mouse Model.
Journal: Scientific reports
Published: January 27, 2016
Protection against multiple subtypes of influenza viruses by virus-like particle vaccines based on a hemagglutinin conserved epitope.
Journal: BioMed research international
Published: October 02, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026